netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

July is Dry Eye Awareness Month

Research to Prevent Blindness (RPB) is proud to lend its support to the vision community and its fellow coalition partners in naming July as Dry Eye Awareness Month, with the goal of enhancing education and communication about this condition. The awareness month coincides with the July publication of the Tear Film & Ocular Surface Society's (TFOS) Dry Eye Workshop II (TFOS DEWS II™) Report in The Ocular Surface journal. In this first re-examination of the topic since the initial report issued in 2007, TFOS DEWS II™ will update the definition, classification, and diagnosis of dry eye; critically evaluate the epidemiology, pathophysiology, mechanism, and impact of the disease; address its management and therapy; and develop recommendations for the design of clinical trials to assess pharmaceutical interventions.

Dry eye, a global problem affecting more than 30 million people in the United States alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly. For some people, it feels like a speck of sand in the eye, or stinging or burning that does not go away. For others, dry eye can become a painful chronic and progressive condition that leads to blurred vision or even vision loss if it goes untreated due to inflammation that can cause ulcers or scars on the cornea, the clear surface of the eye.  Moderate-to-severe dry eye is associated with significant pain, role limitations, low vitality, poor general health, and often depression.

Although researchers have long known about age, sex, and gender as factors, they are now discovering ethnic and racial differences and that dry eye impacts younger patients. It can have many causes, including environmental exposure; side-effects from medications; eye surgery (such as laser correction surgery); lid disorders; immune system diseases such as Sjögren's syndrome, lupus, or rheumatoid arthritis; contact lens wear; cosmetic use; aesthetic procedures; and an increasingly common cause—staring at computer or video screens for too long without blinking.

TFOS DEWS II™ highlights will be presented at a July 12 Congressional Briefing entitled Dry Eye: An Updated Definition, A Greater Impact on Vision Health—co-hosted by TFOS and the Alliance for Eye and Vision Research. The vision community is making Congressional education about dry eye a priority since it impacts healthcare policy, as it is one of the most frequent causes of patient visits to eye care providers, and since federal research funding from the National Institutes of Health, including its National Eye Institute, is being used to study dry eye causes and develop treatments.

The vision community and the following coalition partners, including RPB, are pleased to support the July 2017 Dry Eye Awareness Month educational activities:

Alliance for Eye and Vision Research (AEVR)

American Academy of Ophthalmology

American Academy of Optometry

American Optometric Association

Association for Research in Vision and Ophthalmology

HealthyWomen  

Prevent Blindness  

Research to Prevent Blindness

Sjögren's Syndrome Foundation

Tear Film & Ocular Surface Society (TFOS)

University of Alabama at Birmingham School of Optometry

Women's Eye Health

Women in Ophthalmology

Learn more throughout the month of July at www.tearfilm.org.

 

Related News: Dry Eye, Feature Story, Top Story

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

RPB and AAO Award Grants for Big Data Research to Advance Patient Care

Award recipients to use IRIS Registry database to conduct population-based studies.

Read More

 

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.